Plasma sICAM-1 correlates with tumor volume before primary radiochemotherapy of head and neck squamous cell carcinoma patients
, , , e
13 dic 2022
INFORMAZIONI SU QUESTO ARTICOLO
Categoria dell'articolo: Research Article
Pubblicato online: 13 dic 2022
Pagine: 501 - 507
Ricevuto: 31 ago 2022
Accettato: 29 set 2022
DOI: https://doi.org/10.2478/raon-2022-0043
Parole chiave
© 2022 Kerstin Clasen, Stefan Welz, Heidrun Faltin, Daniel Zips, Franziska Eckert, published by Sciendo
This work is licensed under the Creative Commons Attribution 4.0 International License.
Clasen, Kerstin
Department of Radiation Oncology, Medical Faculty and University Hospital, Eberhard Karls UniversityTuebingen, Germany
Welz, Stefan
Department of Radiation Oncology, Marienhospital StuttgartStuttgart, Germany
Faltin, Heidrun
Section for Experimental Radiation Oncology, Department of Radiation Oncology, Medical Faculty and University Hospital, Eberhard Karls UniversityTuebingen, Germany
Zips, Daniel
Department of Radiation Oncology, Medical Faculty and University Hospital, Eberhard Karls UniversityTuebingen, Germany
German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ) partner site TuebingenTuebingen, Germany
Eckert, Franziska
Department of Radiation Oncology, Medical Faculty and University Hospital, Eberhard Karls UniversityTuebingen, Germany
Section for Experimental Radiation Oncology, Department of Radiation Oncology, Medical Faculty and University Hospital, Eberhard Karls UniversityTuebingen, Germany
German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ) partner site TuebingenTuebingen, Germany
Department of Radiation Oncology, Medical University Vienna, AKH, Comprehensive Cancer CenterVienna, Austria